These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25527701)

  • 21. Recognition of privileged structures by G-protein coupled receptors.
    Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP
    J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
    Vaidehi N
    Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW; Muttenthaler M; Freissmuth M
    Curr Pharm Des; 2010; 16(28):3071-88. PubMed ID: 20687879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
    Li YY; Hou TJ; Goddard WA
    Curr Med Chem; 2010; 17(12):1167-80. PubMed ID: 20158474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidating Ligand-Modulated Conformational Landscape of GPCRs Using Cloud-Computing Approaches.
    Shukla D; Lawrenz M; Pande VS
    Methods Enzymol; 2015; 557():551-72. PubMed ID: 25950981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel G-protein-coupled receptor genes expressed in the brain: continued discovery of important therapeutic targets.
    Lee DK; George SR; O'Dowd BF
    Expert Opin Ther Targets; 2002 Apr; 6(2):185-202. PubMed ID: 12223080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K
    Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling small molecule-compound binding to G-protein-coupled receptors.
    Vaidehi N; Pease JE; Horuk R
    Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
    Valant C; Sexton PM; Christopoulos A
    Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide recognition, signaling and modulation of class B G protein-coupled receptors.
    Cao C; Zhang H; Yang Z; Wu B
    Curr Opin Struct Biol; 2018 Aug; 51():53-60. PubMed ID: 29567494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation.
    Peeters MC; van Westen GJ; Li Q; IJzerman AP
    Trends Pharmacol Sci; 2011 Jan; 32(1):35-42. PubMed ID: 21075459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data.
    Vass M; Podlewska S; de Esch IJP; Bojarski AJ; Leurs R; Kooistra AJ; de Graaf C
    J Med Chem; 2019 Apr; 62(8):3784-3839. PubMed ID: 30351004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors.
    Jacobson KA; Costanzi S
    Mol Pharmacol; 2012 Sep; 82(3):361-71. PubMed ID: 22695719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.
    Chapter MC; White CM; DeRidder A; Chadwick W; Martin B; Maudsley S
    Pharmacol Ther; 2010 Jan; 125(1):39-54. PubMed ID: 19686775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of structure of G-protein coupled receptors and of bound ligands, with applications for drug design.
    Li Y; Goddard WA
    Pac Symp Biocomput; 2008; ():344-53. PubMed ID: 18229698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
    Zeng L; Guan M; Jin H; Liu Z; Zhang L
    Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.